Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)

v3.20.2
Interim Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 27, 2020
Sep. 29, 2019
Sep. 27, 2020
Sep. 29, 2019
Income Statement [Abstract]        
Revenue (note 3) $ 99,547 $ 88,682 $ 285,091 $ 282,267
Cost of sales (note 9) 88,445 79,776 253,664 255,740
Gross profit 11,102 8,906 31,427 26,527
Selling, general and administrative expenses 6,710 6,549 21,036 19,908
Change in fair value of contingent consideration       (3,050)
Restructuring charges (notes 3 and 10) 871 6,454 525 8,624
Operating income 3,521 (4,097) 9,866 1,045
Fair value measurement loss (gain) on warrant liability (note 4) 133 (858) 15 (919)
Interest expense (note 3) 1,941 2,679 6,021 8,349
Net income(loss) before income taxes 1,447 (5,918) 3,830 (6,385)
Income tax expense (recovery) (note 6):        
Current 286 (103) 872 592
Deferred (82) (81) (15) 14
Total income tax expense 204 (184) 857 606
Net income (loss) and comprehensive income (loss) $ 1,243 $ (5,734) $ 2,973 $ (6,991)
Net income (loss) per share:        
Basic $ 0.04 $ (0.20) $ 0.11 $ (0.28)
Diluted $ 0.04 $ (0.20) $ 0.10 $ (0.28)
Weighted average number of shares outstanding (note 7):        
Basic 28,214,800 28,057,763 28,207,943 24,954,875
Diluted 29,636,319 28,057,763 29,629,462 24,954,875